Damora Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $5.9M | $38.2M | $21.5M |
| FY2024 | $1.3M | $17.1M | $14.2M |
| FY2025 | $20.1M | $260.5M | $257.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $5.9M | $38.2M | $21.5M |
| FY2024 | $1.3M | $17.1M | $14.2M |
| FY2025 | $20.1M | $260.5M | $257.6M |